Dynavax Technologies
2100 Powell Street
Suite 300
Emeryville
California
94608
United States
Tel: 510-848-5100
Fax: 510-848-1379
Website: http://www.dynavax.com/
Email: contact@dynavax.com
About Dynavax Technologies
We are developing immunotherapies based on cutting-edge Toll-like receptor (TLR) biology and its ability to modulate the immune system.
463 articles about Dynavax Technologies
-
Dynavax Technologies Corporation Presents Additional Phase 3 Data for HEPLISAV(TM) Hepatitis B Vaccine at EASL Medical Conference
4/27/2009
-
Dynavax Technologies Corporation Presents Additional Phase 3 Data for HEPLISAV Hepatitis B Vaccine at EASL Medical Conference
4/27/2009
-
Dynavax Technologies Corporation Announces Extension of AstraZeneca PLC Research Collaboration
3/11/2009
-
Dynavax Technologies Corporation Appoints Chief Medical Officer
3/4/2009
-
Dynavax Technologies Corporation Announces Fourth Quarter and Year-End 2008 Financial Results
3/2/2009
-
Dynavax Technologies Corporation to Report Fourth Quarter and Year End 2008 Financial Results on March 2, 2009
2/27/2009
-
Company Profile for Dynavax Technologies Corporation
2/27/2009
-
Dynavax Technologies Corporation to Report Fourth Quarter and Year End 2008 Financial Results on March 2, 2009
2/26/2009
-
FDA Asks for More Data on Dynavax Technologies Corporation's Hepatitis Vaccine
2/9/2009
-
Dynavax Technologies Corporation Ends Deal with Merck & Co., Inc. (JOBS) for Hepatitis B Vaccine
12/19/2008
-
GlaxoSmithKline (JOBS), Dynavax Technologies Corporation (JOBS) Forge Drug Research Deal
12/17/2008
-
Dynavax Technologies Corporation Presents Preclinical Data Supporting Its Novel Universal Flu Vaccine Candidate
12/8/2008
-
Dynavax Technologies Corporation Announces Listing Transfer to The Nasdaq Capital Market from The Nasdaq Global Market
11/25/2008
-
Dynavax Technologies Corporation Announces Receipt of Notice of Failure to Satisfy a Continued Listing Rule from The Nasdaq Global Market
11/17/2008
-
Dynavax Technologies Corporation to Present at Credit Suisse Healthcare Conference
11/7/2008
-
Dynavax Technologies Corporation Announces Third Quarter 2008 Financial Results
11/3/2008
-
Dynavax Technologies Corporation to Report Third Quarter 2008 Financial Results
10/31/2008
-
Dynavax Technologies Corporation (JOBS), Merck & Co., Inc. (JOBS) Say Hepatitis Vaccine Still on Hold
10/22/2008
-
Dynavax Technologies Corporation Awarded $17 Million Contract from National Institutes of Health (NIH)
9/29/2008
-
Dynavax Technologies Corporation Receives Milestone from AstraZeneca PLC
9/22/2008